SEC Form 5
FORM 5 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0362
Estimated average burden
hours per response: 1.0
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
Form 3 Holdings Reported.
X
Form 4 Transactions Reported.
1. Name and Address of Reporting Person*
Leonhardt Howard J

(Last) (First) (Middle)
13794 NW 4TH STREET
SUITE 212

(Street)
SUNRISE FL 33325

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BIOHEART, INC. [ bhrt ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
Chief Technology Officer
3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
12/31/2010
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Amount (A) or (D) Price
Common Stock 03/29/2010 P4 3,136,520 A $0.66 7,877,903 D(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
(A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $5.67 12/31/2005 12/30/2011 Common Stock 23,167 26,379 D
Stock Option (right to buy) $5.67 12/31/2005 12/30/2015 Common Stock 3,212 26,379 D
Warrant (right to buy) $0.82 11/14/2009 05/14/2012 Common Stock 38,823 1,030,989 D
Warrant (right to buy) $0.9 11/29/2009 05/29/2012 Common Stock 18,801 1,030,989 D
Warrant (right to buy) $0.89 12/04/2009 06/04/2012 Common Stock 12,972 1,030,989 D(2)
Warrant (right to buy) $0.85 12/11/2009 06/11/2012 Common Stock 19,437 1,030,989 D(2)
Warrant (right to buy) $0.79 03/29/2010 4A 940,956 09/29/2010 03/29/2013 Common Stock 940,956 $0 1,030,989 D(2)
Warrant (right to buy) $7.69 06/01/2008 05/31/2017 Common Stock 203,870 407,738 D(2)
Warrant (right to buy) $7.69 10/10/2008 10/09/2017 Common Stock 203,868 407,738 D(2)
Explanation of Responses:
1. Shares are directly and jointly held by Mr. Leonhardt and his former spouse.
2. Warrant issued to Mr. Leonhardt and his former spouse.
/s/Catherine Sulawske-Guck (attorney-in-fact) 04/01/2011
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.